-
New ferring.com goes live
inToday Ferring Pharmaceuticals launches its new corporate website. In addition to an all-new design and improved functionality, more than 150 pages of new content allow web visitors to learn about Ferring and in particular its therapeutic areas…
0 -
Mrs. Eva Paulsen, Ferring co-Founder, dies at 86
inFerring founder, Mrs. Eva Paulsen died last week; at the age of 86…
-
Degarelix, a new GnRH blocker from Ferring
inThe first results from trials of degarelix in patients were presented today…
-
Volume of urine as a useful indicator of Nocturnal Polyuria
inMillions of sufferers who take frequent night time toilet visits can now help to diagnose themselves with a simple home test…
-
New nocturia section launched on MINIRIN.com
inIn July Ferring’s urology division launched a nocturia section on www.MINIRIN.com in addition to the bedwetting information on the website…
-
Ferring Kicks Off Campaign for Newest Product NORPROLAC at the International ESHRE Conference in Berlin
inFerring France officially launches NORPROLAC, as a first start to a world-wide campaign…
-
International experts recommend that children who want to be treated for bedwetting should be offered desmopressin or alarm therapy
inFerring Pharmaceuticals, known for its commitment to paediatric health, is pleased to announce that…
-
Ferring building receives award
inIn the beginning of 2003 the Danish magazine “Byggeri” granted Ferring International Center an award for “Building of the Year 2002”…
-
Ferring appoints President of the Ferring Research Institute
inFerring, a biopharmaceutical company with its headquarters in Lausanne, Switzerland announced today that Dr. John L. McGuire has been appointed as the President of the Ferring Research Institute…
-
Dr Eberhard Zinn, Ferring Board Member, dies at 66
inFerring founding board member, Dr. Eberhard Zinn died last week; he was 66 years old…
PRESS RELEASE 2004
PRESS RELEASE 2004